A survey on anticancer properties of batch cultured cell free supernatant of Lactobacillus reuteri on k562 (myeloid leukemia cancer)cell line
A survey on anticancer properties of batch cultured cell free supernatant of Lactobacillus reuteri on k562 (myeloid leukemia cancer)cell line
shahla javanian1 Peyma zare2
IOI Code
:
XYHD-BFZAZ
Publication :
International Conference On Research Science And Technology(restconf.org)
Abstract :
Abstract
Introduction: K562 cell line as one of the most popular models on gastrointestinal tumors known .Various treatments such as interferon and chemotherapy have been used. Although these methods of inhibiting the cancer have been reported to be successful in some cases, still there is a long way to go to reach the favorable clinical response. Side effects and toxicity of these drugs also cause severe damage to patients. Lactobacillus reuteri is among the normal flora of human intestine and the anticancer effects of its products has been shown in numerous studies.
Objective: In current study, anticancer effects of cellular components and the supernatant from batched cultured Lactobacillus reuteri was investigated.
Materials and Methods: Batch culture procedures were performed according to the routine standards and industrial strain of Lactobacillus reuteri was cultured in MRS broth to reach the stationary phase of growth. Then cell free supernatant (CFS) was harvested and neutralized (pH set to 7.2). Finally, K562 cells were exposed to the CFS and relative cell viability was measured by MTT assay.
Results: The results from MTT assay revealed severe cell toxicity of the CFS even in low concentrations (1:32).
Conclusion: According to the results of this study, it can be concluded that Lactobacillus reuteri is able to produce anticancer compounds which can effectively damage neoplastic cells.
Keywords : gastric cancar cells , K562 cell line, Lactobacillus reuteri , anticancer, cell free supernatant, MTT
Keywords : cancer cells k562 (myeloid leukemia cancer)cell lines lactobacillus reuteri anti tumor supernatant mtt